RCS-21 / RNATICS - LARVOL DELTA

AMIR-21: Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers. (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: RNATICS GmbH | N=48 ➔ 24 | Trial completion date: Mar 2026 ➔ Aug 2026 | Trial primary completion date: Jan 2026 ➔ Jun 2026

Enrollment change • Trial completion date • Trial primary completion date

AMIR-21: Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers. (clinicaltrials.gov) - P1 | N=48 | Recruiting | Sponsor: RNATICS GmbH | Not yet recruiting ➔ Recruiting

Enrollment open